The Nigeria Centre for Disease Control and Prevention (NCDC) has reported that two people investigated for suspected Ebola virus disease in Yola, Adamawa State, tested negative following two rounds of laboratory examinations, ruling out confirmed infection in the state at the time of the update.
According to a statement attributed to NCDC Director-General Dr. Jide Idris, the patients were identified through surveillance activities in the North East, isolated as a precaution and assessed while public health officials began identifying possible contacts.
The agency said the laboratory results were negative and emphasized that suspected cases must not be presented as confirmed infections. It commended the Adamawa State Government for responding promptly and urged Nigerians to avoid circulating unverified reports.
The development follows Nigeria’s confirmation of an imported Ebola case in the Federal Capital Territory on October 20, 2026. An NCDC situation report dated October 24 identified the infection as involving the Bundibugyo species of Ebola virus and recorded 53 contacts under follow-up. The report also documented a separate suspected case in Rivers State that tested negative.
The imported case involved a woman who travelled to Abuja from Uganda through Addis Ababa in early October. According to NCDC’s published epidemiological account, she developed symptoms days after arriving and was later confirmed positive through laboratory testing. The agency activated its incident management arrangements and contact tracing.
The latest account supplied to Xposure News states that the patient was subsequently transferred to Switzerland for further care and that the federal authorities introduced financial support for monitored contacts. Those subsequent developments, including the precise transfer arrangements and payment terms, should be checked against updated official releases before publication.
Health authorities have continued to emphasize early reporting of suspected symptoms, careful contact monitoring and adherence to infection prevention guidance. NCDC’s published updates support the existence of the single confirmed imported case, but the specific negative test results for the two Adamawa patients still require confirmation against the agency’s latest public bulletin.
